Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Harpoon Therapeutics Inc (NQ: HARP ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Mar 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 23.00 (6) Ask (Size) 23.01 (36) Prev. Close 23.01 Today's Range N/A - N/A 52wk Range 3.110 - 23.21 Shares Outstanding 37,595,787 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Analyst Scoreboard: 4 Ratings For Harpoon Therapeutics February 26, 2024 Via Benzinga Harpoon Therapeutics Inc. (NASDAQ: HARP) Records 52-Week High Thursday Morning February 22, 2024 Via Investor Brand Network Performance More News Read More Merck Posts Surprise Quarterly Profit Against An Expected Loss, Oncology And Vaccines Drive Growth February 01, 2024 Via Benzinga Investor Optimism Around Keytruda Drives Merck Stock To Golden Cross Ahead of Earnings January 29, 2024 Via Benzinga This 1 Bullish Move by Merck Could Drive Growth for Years to Come January 23, 2024 Via The Motley Fool The 3 Best Dividend Growth Stocks to Buy in January 2024 January 17, 2024 Via InvestorPlace Peeling Back The Layers: Exploring Harpoon Therapeutics Through Analyst Insights January 16, 2024 Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP) January 16, 2024 From Brodsky & Smith LLC Via GlobeNewswire Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review January 12, 2024 Via Investor's Business Daily Topics ETFs HARPOON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Harpoon Therapeutics, Inc. - HARP January 10, 2024 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP) January 08, 2024 From Brodsky & Smith LLC Via GlobeNewswire Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results January 08, 2024 Via Benzinga Topics Stocks Exposures US Equities Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 08, 2024 Via Benzinga Harpoon Therapeutics Inc. (NASDAQ: HARP) Near the Top of Equities by Percentage Gain on 1/8 January 08, 2024 Via Investor Brand Network 12 Health Care Stocks Moving In Monday's Intraday Session January 08, 2024 Via Benzinga Crude Oil Falls Sharply; Ambrx Biopharma Shares Spike Higher January 08, 2024 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Today Is Cancer-Focused Deals Day: Johnson & Johnson Scoops Up Ambrx Biopharma As Merck Boosts Cancer Portfolio With Harpoon Deal January 08, 2024 Via Benzinga Health Care Company Merck & Co Announces Acquisition of Harpoon Therapeutics January 08, 2024 Via Benzinga US Stocks Mixed; Nasdaq Jumps Over 100 Points January 08, 2024 Via Benzinga Topics Stocks Exposures US Equities Merck, the Dow's hottest stock, gets set to report Q4 financials January 08, 2024 Via MarketBeat Topics Stocks Exposures US Equities J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value January 08, 2024 Via Investor's Business Daily Why Is Spirit AeroSystems (SPR) Stock Down 14% Today? January 08, 2024 Via InvestorPlace Why Is LumiraDx (LMDX) Stock Down 13% Today? January 08, 2024 Via InvestorPlace Why Is Cellectar Biosciences (CLRB) Stock Up 16% Today? January 08, 2024 Via InvestorPlace HARP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Harpoon Therapeutics, Inc. Is Fair to Shareholders January 08, 2024 From Halper Sadeh LLC Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.